Retraction
Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression
Paper Information
Record ID:
64835
Author(s):
Publication Date:
April 28, 2015
Retraction Date:
April 02, 2024
(1.6 year years ago)
Subjects:
Institutions:
- Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education, and State Key Laboratory of Natural and Biomimetic Drugs, Peking University Health Science Center, Beijing, PR China
- Department of Anatomy, Histology and Embryology, Peking University Health Science Center, Beijing, PR China
- Department of Histology and Embryology and Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education, Shihezi University School of Medicine, Shihezi, Xinjiang, PR China
- Department of Pathology, Peking University Health Science Center, Beijing, PR China
- Institute of Pathology and Laboratory Medicine, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio, United States of America
- Department of Quantitative Health Sciences, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio, United States of America
Countries:
Article Type:
Publisher:
PLoS
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1371/journal.pone.0301575Citations (40)
40
Total Citations1
Post-Retraction(2.5%)
35
Pre-Retraction4
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
28
Days since retraction (latest)
Identifying SCC Lesions Capable of Spontaneous Regression by Using Immunohistochemistry: A Systematic Review and Meta-Analysis Study
Maryam Hedayati, Behzad Garousi, Zahrasadat Rezaei et al. (11 authors)
Dermatology Practical & Conceptual
Open Access
Published: Apr 2024
1 citation
1 citation
28 days after retraction
Retraction: The Significance of Notch1 Compared with Notch3 in High Metastasis and Poor Overall Survival in Hepatocellular Carcinoma
Unknown Authors
PLoS ONE
Open Access
Published: Apr 2024
3 citations
3 citations
Same day as retraction
Retraction: Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression
Unknown Authors
PLoS ONE
Open Access
Published: Apr 2024
3 citations
3 citations
Same day as retraction
Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma
Unknown Authors
PLoS ONE
Open Access
Published: Apr 2024
3 citations
3 citations
Same day as retraction
Retraction: SATB1 Overexpression Regulates the Development and Progression in Bladder Cancer through EMT
Unknown Authors
PLoS ONE
Open Access
Published: Apr 2024
3 citations
3 citations
Same day as retraction
The role of RNA-modifying proteins in renal cell carcinoma
Muna A. Ali, Khuloud Bajbouj, Iman M. Talaat et al. (4 authors)
Cell Death and Disease
Open Access
Published: Mar 2024
6 citations
6 citations
14 days before retraction
Insulin-like Growth Factor II mRNA-binding Protein 3 is a Highly Sensitive Marker for Intravascular Large B-cell Lymphoma
Manduwa Saka, Masakazu Fujimoto, Kai Mizoguchi et al. (19 authors)
The American Journal of Surgical Pathology
Published: Mar 2024
1 citation
1 citation
15 days before retraction
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application
Lei Yang, Jianming Ying, Qian Tao et al. (4 authors)
Nature Reviews Urology
Published: Feb 2024
10 citations
10 citations
50 days before retraction
RNA binding proteins in cancer chemotherapeutic drug resistance
Hemanathan Vembuli, Ravi Gor, Satish Ramalingam et al. (5 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Jan 2024
3 citations
3 citations
69 days before retraction
circRARS synergises with IGF2BP3 to regulate RNA methylation recognition to promote tumour progression in renal cell carcinoma
Yuenan Liu, Kailei Chen, Yi Shou et al. (13 authors)
Clinical and Translational Medicine
Open Access
Published: Dec 2023
11 citations
11 citations
123 days before retraction
IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas
Natividad Martín‐Morales, Miguel Padial‐Molina, I. Tovar et al. (13 authors)
Pathobiology
Published: Oct 2023
180 days before retraction
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma
Yige Wu, Siqi Chen, Xiaolu Yang et al. (39 authors)
Cancer Research
Open Access
Published: Sep 2023
11 citations
11 citations
188 days before retraction
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated Liposarcoma
Kyle D. Klingbeil, Jack Pengfei Tang, Danielle S. Graham et al. (15 authors)
Cancers
Open Access
Published: Sep 2023
3 citations
3 citations
206 days before retraction
IGF2BPs as novel m6A readers: Diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment
Meiqi Duan, Haiyang Liu, Shasha Xu et al. (9 authors)
Genes & Diseases
Open Access
Published: Jul 2023
28 citations
28 citations
257 days before retraction
Ascorbic acid protects retinal pigment epithelial cells from high glucose by inhibiting the <scp>NF‐κB</scp> signal pathway through <scp>MALAT1</scp>/<scp>IGF2BP3</scp> axis
Yanming Tian, Wubo Cheng, Haiyan Wang et al. (5 authors)
Diabetic Medicine
Published: Jan 2023
6 citations
6 citations
438 days before retraction
Prognosis and pain dissection of novel signatures in kidney renal clear cell carcinoma based on fatty acid metabolism-related genes
Ruifeng Ding, Huawei Wei, Xin Jiang et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Dec 2022
3 citations
3 citations
480 days before retraction
Deletion of Insulin-like growth factor II mRNA-binding protein 3 participates in the pathogenesis of recurrent spontaneous abortion by inhibiting IL-10 secretion and inducing M1 polarization
Yuwei Zhang, Fangfang Dai, Dongyong Yang et al. (13 authors)
International Immunopharmacology
Published: Dec 2022
11 citations
11 citations
488 days before retraction
Cancer germline antigens and tumor-agnostic CD8+ T cell evasion
Dian Kortleve, Rui M. L. Coelho, Dora Hammerl et al. (4 authors)
Trends in Immunology
Open Access
Published: Apr 2022
10 citations
10 citations
723 days before retraction
LncRNA CDKN2B-AS1 stabilized by IGF2BP3 drives the malignancy of renal clear cell carcinoma through epigenetically activating NUF2 transcription
Xina Xie, Jiatian Lin, Xiaoqin Fan et al. (12 authors)
Cell Death and Disease
Open Access
Published: Feb 2021
48 citations
48 citations
1138 days before retraction
<i>DMDRMR</i>-Mediated Regulation of m6A-Modified <i>CDK4</i> by m6A Reader IGF2BP3 Drives ccRCC Progression
Yinmin Gu, Shaoxi Niu, Yang Wang et al. (23 authors)
Cancer Research
Open Access
Published: Dec 2020
139 citations
139 citations
1211 days before retraction
IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer
Wei Huang, Yuanyuan Li, Cheng Zhang et al. (8 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Oct 2020
106 citations
106 citations
1258 days before retraction
Significance of Insulin-Like Growth Factor II Mrna-Binding Protein 3 (IMP3) Expression in Selected Thyroid Lesions
Taghreed Abd El Samee Abd El Aziz, Ranih Zakaria Amer, Hanan Ahmed Sayed-Ahmed et al. (4 authors)
Benha Medical Journal
Open Access
Published: Jun 2020
2 citations
2 citations
1401 days before retraction
Proapoptotic and Antiangiogenic Activities of <i>Arctium Lappa</i> L. on Breast Cancer Cell Lines
M. Taleb Agha, Hussein M. Baharetha, Majed Ahmed Al‐Mansoub et al. (7 authors)
Scientifica
Open Access
Published: May 2020
20 citations
20 citations
1414 days before retraction
Biological functions and prognostic value of RNA Binding Proteins in clear cell Renal Cell Carcinoma
Zhenpeng Zhu, Anbang He, Lanruo Lin et al. (6 authors)
Journal of Cancer
Open Access
Published: Jan 2020
10 citations
10 citations
1553 days before retraction
The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis
Yong Wang, Jing Su, Yi‐Ting Wang et al. (12 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Sep 2019
67 citations
67 citations
1673 days before retraction
Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy
Yongchang Lai, Tao Zeng, Xiongfa Liang et al. (6 authors)
Cancer Cell International
Open Access
Published: Aug 2019
41 citations
41 citations
1684 days before retraction
Overview of established and emerging immunohistochemical biomarkers and their role in correlative studies in MRI
Emaan Alvi, Rajarsi Gupta, Raphael Borok et al. (5 authors)
Journal of Magnetic Resonance Imaging
Published: Apr 2019
5 citations
5 citations
1799 days before retraction
TUSC3 as a potential biomarker for prognosis in clear cell renal cell carcinoma
Youji Yan, Zhongjun Chen, Yixiang Liao et al. (4 authors)
Oncology Letters
Open Access
Published: Mar 2019
5 citations
5 citations
1841 days before retraction
Bufalin suppresses the proliferation and metastasis of renal cell carcinoma by inhibiting the PI3K/Akt/mTOR signaling pathway
Jinlin Xie, Wenfeng Lin, Linglong Huang et al. (9 authors)
Oncology Letters
Open Access
Published: Jul 2018
36 citations
36 citations
2093 days before retraction
The expression of IMP3 in 366 cases with ovarian carcinoma of high grade serous, endometrioid and clear cell subtypes
Linghui Lu, Shunni Wang, Qin Zhu et al. (8 authors)
Pathology - Research and Practice
Open Access
Published: May 2018
10 citations
10 citations
2135 days before retraction
Selection of biomarkers for HIV-1 latency by integrated analysis
Sun Young Lee, Byeong‐Sun Choi, Cheol‐Hee Yoon et al. (6 authors)
Genomics
Open Access
Published: Feb 2018
9 citations
9 citations
2239 days before retraction
Renal Cell Carcinoma: Molecular Aspects
Aman Kumar, Niti Kumari, Vinny Gupta et al. (4 authors)
Indian Journal of Clinical Biochemistry
Open Access
Published: Nov 2017
53 citations
53 citations
2332 days before retraction
Prognostic value of high IMP3 expression in solid tumors: a meta-analysis
Luyao Chen, Yongpeng Xie, Xintao Li et al. (8 authors)
OncoTargets and Therapy
Open Access
Published: Jun 2017
21 citations
21 citations
2497 days before retraction
IGF2 mRNA binding protein 3 (IMP3) promotes glioma cell migration by enhancing the translation of RELA/p65
Shruti Bhargava, Abhirami Visvanathan, Vikas Patil et al. (10 authors)
Oncotarget
Open Access
Published: Apr 2017
31 citations
31 citations
2544 days before retraction
Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data
Jacqueline M. Speed, Quoc‐Dien Trinh, Toni K. Choueiri et al. (4 authors)
Current Urology Reports
Published: Feb 2017
71 citations
71 citations
2617 days before retraction
Anti-Metastatic Effect of Semi-Purified<i> Nuphar Lutea</i> Leaf Extracts
Janet Ozer, Daniel Fishman, Brit Eilam et al. (5 authors)
Journal of Cancer
Open Access
Published: Jan 2017
14 citations
14 citations
2648 days before retraction
Biomarkers of Renal Cancer
Naveen Vasudev, Rosamonde E. Banks
Elsevier eBooks
Published: Nov 2016
6 citations
6 citations
2699 days before retraction
Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression
Rui Bi, Xuxia Shen, Lillian Weiwei Zhang et al. (7 authors)
Diagnostic Pathology
Open Access
Published: Feb 2016
12 citations
12 citations
2982 days before retraction
Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma
Akiko Kanzaki, Mitsuhiro Kudo, Shin‐ichi Ansai et al. (15 authors)
International Journal of Oncology
Open Access
Published: Jan 2016
26 citations
26 citations
3010 days before retraction
EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression
Xianglan Zhang, Im‐Hee Jung, Young Sun Hwang
Tumor Biology
Published: Sep 2015
13 citations
13 citations
3118 days before retraction
Quick Stats
Total Citations:
40
Years Since Retraction:
1.6 year
Open Access:
Yes
Last Checked:
Jul 24, 2025